Compare drug alternatives
Emgality® Alternatives
Emgality®
(Galcanezumab)
Emgality
-
Migraine
- Vyepti®
- Aimovig®
- Ajovy®
- Nurtec ODT®
- Qulipta®
Prescription Only
Emgality is a medication that can be self-administered once a month by injecting it subcutaneously under the skin. It is used for migraine prevention in adults and can also be used to treat cluster headaches during a cluster headache period. The most frequently reported side effect is injection site reactions. Additionally, there are no known drug interactions with Emgality.
Emgality is FDA approved for the following indications: Migraine and Cluster Headaches.
Ubrelvy®
(ubrogepant)
Ubrelvy
-
Migraine
- Vyepti®
- Aimovig®
- Ajovy®
- Nurtec ODT®
- Qulipta®
Prescription Only
Ubrelvy is a medication that adults can use to treat acute migraine attacks. It works by blocking CGRP, a protein believed to contribute to migraine attacks by causing pain, blood vessel dilation, and inflammation. Ubrelvy is well-tolerated, with less than 5% of individuals reporting side effects such as nausea, somnolence, and dry mouth. Ubrelvy does not prevent migraines.
Ubrelvy is FDA approved for the following indications: Migraine.
Dosage & Administration
Administration
Subcutaneous
Oral
Dosing
Migraine: 240 mg loading dose (120 mg x 2) followed by 120 mg monthly.
50 mg or 100 mg as needed. Maximum daily dose: 200 mg. Severe Hepatic or Severe Renal Impairment: 50 mg.
Latin Shorthand
240 mg LD (120 mg x 2) then 120 mg/mo.
50 mg PRN or 100 mg PNR. Severe Renal Impairment: 50mg.
Financial Assistance
Copay
$0
$0
Annual Cap
$4,900
Maximum savings of $50 per pill for up to 13 prescription fills.
Assistance Expiration
12 months
13 prescription fills
Generics
No lower-cost generic available
No lower-cost generic available